“There are literally tens of thousands of patents claiming DNA that we would not consider to be a product of nature,” and which therefore are fine according to Thursday’s decision, said Gregory Graff, a professor at Colorado State University who led an analysis of gene patents published last month in Nature Biotechnology.

link